DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Torisel (Temsirolimus) - Gastrointestinal Haemorrhage - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Gastrointestinal Haemorrhage (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Torisel (Temsirolimus) where reactions include gastrointestinal haemorrhage. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Torisel side effects in 53 year old male

Reported by a physician from Japan on 2012-08-09

Patient: 53 year old male, weighing 65.0 kg (143.0 pounds)

Reactions: Gastrointestinal Haemorrhage, Stomatitis, Fungal Infection, Interstitial Lung Disease, Haemorrhagic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 25 mg, weekly
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-05-08
    End date: 2012-07-10

Torisel
    Indication: Metastases To Liver

Torisel
    Indication: Metastases To Lung

Other drugs received by patient: Naproxen; Celebrex; Lansoprazole; Celebrex; Feburic



Possible Torisel side effects in 76 year old male

Reported by a physician from France on 2012-07-05

Patient: 76 year old male

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: unk
    Indication: Antiangiogenic Therapy
    Start date: 2009-07-28

Torisel
    Dosage: cycle 33
    Start date: 2010-03-31
    End date: 2010-03-31

Other drugs received by patient: Trandolapril; Atorvastatin; Novolog MIX 70 / 30; Prednisolone; Nebivolol HCL; Calcidia; Kardegic; Novorapid; Pantoprazole Sodium; Lasix



Possible Torisel side effects in 66 year old female

Reported by a physician from France on 2012-05-30

Patient: 66 year old female

Reactions: Gastrointestinal Haemorrhage, Febrile Neutropenia, Febrile Bone Marrow Aplasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Torisel
    Indication: Mantle Cell Lymphoma Recurrent

Cyclophosphamide
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Torisel
    Dosage: 25 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-27
    End date: 2012-02-02

Prednisone TAB
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Rituximab
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Cyclophosphamide
    Indication: Mantle Cell Lymphoma Recurrent

Vincristine Sulfate
    Indication: Mantle Cell Lymphoma Recurrent

Prednisone TAB
    Indication: Mantle Cell Lymphoma Recurrent

Cyclophosphamide
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma Recurrent

Rituximab
    Indication: Mantle Cell Lymphoma Recurrent



Possible Torisel side effects in 66 year old female

Reported by a individual with unspecified qualification from United States on 2012-05-25

Patient: 66 year old female

Reactions: Gastrointestinal Haemorrhage, Febrile Bone Marrow Aplasia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Torisel
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-27
    End date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Doxorubicin HCL
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Vincristine Sulfate
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Cyclophosphamide
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30



Possible Torisel side effects in 51 year old male

Reported by a physician from Switzerland on 2012-04-30

Patient: 51 year old male

Reactions: Gastrointestinal Haemorrhage

Drug(s) suspected as cause:
Torisel



Possible Torisel side effects in female

Reported by a physician from France on 2012-04-18

Patient: female

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 25 mg, unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-27
    End date: 2012-02-02

Doxorubicin HCL
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Prednisolone
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Cyclophosphamide
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Rituximab
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Vincristine Sulfate
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30



Possible Torisel side effects in 66 year old female

Reported by a physician from France on 2012-04-06

Patient: 66 year old female

Reactions: Gastrointestinal Haemorrhage, Febrile Bone Marrow Aplasia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Mantle Cell Lymphoma Recurrent

Rituximab
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Cyclophosphamide
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Prednisone
    Indication: Mantle Cell Lymphoma Recurrent

Doxorubicin HCL
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Vincristine Sulfate
    Indication: Mantle Cell Lymphoma Recurrent

Cyclophosphamide
    Indication: Mantle Cell Lymphoma Recurrent

Torisel
    Dosage: 25 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-27
    End date: 2012-02-02

Vincristine Sulfate
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Prednisone
    Dosage: unk
    Indication: Mantle Cell Lymphoma
    Start date: 2012-01-26
    End date: 2012-01-30

Torisel
    Indication: Mantle Cell Lymphoma Recurrent

Rituximab
    Indication: Mantle Cell Lymphoma Recurrent



Possible Torisel side effects in 66 year old female

Reported by a physician from France on 2012-03-19

Patient: 66 year old female

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Vincristine Sulfate
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Cyclophosphamide
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Prednisolone
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Doxorubicin HCL
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-26
    End date: 2012-01-30

Torisel
    Dosage: 25 mg, unk
    Indication: Mantle Cell Lymphoma Recurrent
    Start date: 2012-01-27
    End date: 2012-02-02

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017